TNFRSF1B and rheumatoid arthritis: Resistance to infliximab treatment in RA patients could be circumvented with etanercept, a TNFR2-Fc fusion protein also blocking LTα, indicating that LTα plays an important, in some patients apparently a dominant role in this disease [63].